AMCP Holds Annual Legislative Days Event

Alexandria, Va., March 5, 2018 — The Academy of Managed Care Pharmacy (AMCP) will hold its annual Legislative Days event on March 6 and 7. Teams of AMCP volunteer leaders and staff will visit more than 50 House and Senate offices to advocate on two crucial issues affecting managed care pharmacy. They are: 

Passage of the Pharmaceutical Information Exchange (PIE) Act of 2018 (H.R. 2026): The PIE Act would allow biopharmaceutical manufacturers to proactively share truthful and non-misleading clinical and economic information about medications in the pipeline with population health decision makers at least 12-18 months prior to FDA approval, during the forecasting and rate setting process. AMCP has been leading advocacy efforts on H.R. 2026 as it will allow decision makers to expedite coverage decisions as soon as new medications hit the market. The PIE Act recently passed the House Energy & Commerce Committee’s Subcommittee on Health, and is now before the full E&C Committee. A vote is expected soon.

Initiatives to reduce fraud, waste and abuse under the Medicare Part D program: In 2016, the federal government spent $1 trillion on Medicare Part D, but CMS estimated that $2.39 billion of that total was for improper prescription payments. AMCP supports reducing the current practice of “pay and chase,” to recover fraudulent payments. Part D Prescription Drug Plan (PDP) sponsors can and should play an important role in fighting fraud in the Medicare Part D Program. Greater involvement by PDP sponsors will reduce the incidence of fraud and result in substantial savings for beneficiaries and taxpayers.

"AMCP works continuously on behalf of our members, including on these issues and others," said AMCP CEO Susan A. Cantrell, RPh, CAE. "We are cementing our reputation in Washington as the 'go-to' organization for population health management and design of medication benefits." 

For more information on our positions on these and other issues, please visit Federal/State Legislative-Regulatory Issues.